Definium Therapeutics Inc.
DFTX | NASDAQ
$33.77
-$2.56 (-7.05%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.50 | -4.52 | -1.50 | -1.44 | -6.09 | -23.83 |
PEG Ratio | -0.19 | 0.12 | -0.03 | 0.03 | -0.08 | 0.69 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.60 | 2.03 | 1.83 | 0.45 | 3.74 | 10.70 |
P/FCF Ratio | -9.09 | -6.20 | -2.23 | -1.35 | -12.37 | -34.41 |
P/OCF Ratio | -9.09 | -6.20 | -2.23 | -1.35 | -12.37 | -34.41 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | 0.09 | 0.18 | 0 | n/a | n/a |
Quick Ratio | 6.29 | 7.25 | 3.22 | 8.16 | 13.18 | 27.10 |
Current Ratio | 6.29 | 7.25 | 3.22 | 8.16 | 13.18 | 27.10 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -30.34 | -45.52 | -102.03 | -44.37 | -261.43 | -201.40 |
Return on Equity | -55.30% | -45.01% | -122.52% | -37.63% | -61.34% | -44.95% |
Return on Assets | -41.76% | -35.97% | -76.87% | -33.41% | -56.73% | -41.83% |
Return on Invested Capital | -44.54% | -39.47% | -101.70% | -43.59% | -60.35% | -42.07% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DFTX